Medical Implants in the New Biomedical Frontier

More than a million tissue transplants and medical device implants were performed in 2005, according to available estimates. It is reported that the organ and tissue transplantation market in the U.S. was valued at more than $11 billion in 2005. Today, the multi-billion-dollar biomedical industry continues to expand well beyond its more humble origins of blood, organ and tissue banking. These developing biotechnologies have forced courts to address novel issues and concerns regarding a new generation of biosurgical implants outside the parameters of settled judicial and statutory frameworks dealing with medical implants. The widespread usage of such new implants has also called into question the settled case law that hospitals and physicians may not be held strictly liable for the implantation of defective medical device products.

19 minute read April 27, 2006 at 02:31 PM
By
Neal A. DeYoung
Medical Implants in the New Biomedical Frontier

More than a million tissue transplants and medical device implants were performed in 2005, according to available estimates. It is reported that the organ and tissue transplantation market in the U.S. was valued at more than $11 billion in 2005.

This premium content is locked for LawJournalNewsletters subscribers only

ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts
Subscribe Now

Already have an account? Sign In Now

For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.

NOT FOR REPRINT

© 2026 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Continue Reading

How Courts Interpret and Apply the Interplay Between the Bankruptcy Code and Medicare Program Act

The combination of increasing operating costs and uncertain government reimbursement funding continues to place health care providers under financial pressure, and in many cases, financial distress. Given the importance of Medicare/Medicaid funding of claims under provider agreements with the federal government, how courts interpret and apply the interplay between the Bankruptcy Code and Medicare Program Act determines the disposition of hundreds of millions of dollars of claims for reimbursement that support the health care system.

April 30, 2026

AI Transparency: Clear Explanations Matter More Than Disclosure

As AI becomes embedded in everyday business and legal operations, organizations are confronting a new expectation: simply disclosing AI use is no longer enough. A critical shift is taking place in the legal industry: transparency is no longer just about disclosure; it’s about comprehension.

April 30, 2026